This article considers the differences and similarities between the EU laws (in particular the UK and French systems) and the US laws as they relate to marketing, e-commerce and advertising in the pharmaceutical industry. Specifically, the article examines who regulates pharmaceutical advertising, the basic advertising rules, patient contact, comparative advertising and sanctions for non-compliance.